Lack of structural rearrangement in c-kit and stem cell factor genes in Hong Kong Chinese patients with myelodysplastic syndromes or acute myeloid leukaemia

Hong Kong Medical Journal

Volumn 4, Issue 1, 1998, Pages 27-30

  Chui, C H ^a   Leung, P H M ^b   Lau, F Y ^a   Wan, T S K ^a   Chan, L C ^a   Cheng, G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Acute; Blotting; Leukemia; Myelocytic; Myelodysplastic syndromes; Proto oncogene proteins c kit genetics; Southern; Stem cell factor

Indexed keywords

STEM CELL FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; C KIT GENE; CONTROLLED STUDY; CYTOCHEMISTRY; GENE; GENE DELETION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; SOUTHERN BLOTTING;

EID: 84988045173     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-24.
2. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988;335:88-9.
3. Nocka K, Majumder S, Chabot B, et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev 1989;3:816-26.
4. Beechey CV, Searle AG. Male fertile black-eyed white at SI locus. Mouse Newsletter 1985:73:17-22.
5. Roussel MF, Downing JR, Rettenmier CW, Sherr CJ. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fnis proto-oncogene product) activates its transforming potential. Cell 1988;55:979-88.
6. Kitayama H., Kanakura Y, Furitsu T, et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorgenicity of factor-dependent hematopoietic cell lines. Blood 1995;85:790-8.
7. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated haematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-4.
8. Furitsu T, Tsujimura T, Tono T. et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;92: 1736-44.
9. Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD. The expression of the proto-oncogene C-kit in the blast cells of acute myeloblasts leukemia. Leukemia 1989;3:699-702.
10. Hirokazu I, Yuzuru K, Toshiharu T, et al. Expression and functional role of the proto-oncogene c-kit in acute myeloblasts leukemia cells. Blood 1991;78:2962-8.
11. Cheng G, Titley P, Minden MD. Aye MT, McCulloch EA. Structural alterations of the c-kit proto-oncogene in patients with acute myelogenous leukaemia. Int J Cell Cloning 1991;9:349-53.
12. Backx B, Broeders L, Lowenberg B. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood 1992;80:1213-7.
13. Verbeek W, Vehmeyer K, Wormann B, Hiddemann W. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes. J Cancer Res Clin Oncol 1995;121:338-42.
14. Chui CH, Lau FY, Lee FC, Chan LC, Cheng G. Low frequency of c-kit expression and detection of an aberrant Kit message among Hong Kong Chinese myelogenous leukaemia patients. Cancer Lett 1997;116:253-8.
15. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
16. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
17. Ikuta K, Weissman IL. Evidence that haematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 1992;89:1502-6.
18. Sutherland HJ, Hogge DE, Cook D, Eaves CJ. Alternative mechanisms with and without steel factor support primitive human haematopoiesis. Blood 1993;81:1465-70.
19. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991;65:1143-52.
20. Birg F, Courcoul M, Rosnet O, et al. Expression of the FMSI ATfV-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992;80:2584-93.
21. Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA. Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leuk Res 1988;12:923-8.